Both MHC I and MHC II Pathways Are Associated with Improved Survival in Triple-Negative Breast Cancer

被引:0
|
作者
Iqbal, Jabed
Yeong, Joe
Lee, Bernett
Lim, Jeffrey C. T.
Cheng, Xin Min
Tan, Puay Hoon
机构
[1] Singapore Gen Hosp, Singapore, Singapore
[2] ASTAR, Singapore, Singapore
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
1840
引用
收藏
页码:458A / 458A
页数:1
相关论文
共 50 条
  • [31] The influence of comorbidity on treatment and survival of triple-negative breast cancer
    Parise, Carol A.
    Caggiano, Vincent
    BREAST JOURNAL, 2020, 26 (09): : 1729 - 1735
  • [32] Beta-Blocker Use Is Associated With Improved Relapse-Free Survival in Patients With Triple-Negative Breast Cancer
    Melhem-Bertrandt, Amal
    Chavez-MacGregor, Mariana
    Lei, Xiudong
    Brown, Erika N.
    Lee, Richard T.
    Meric-Bernstam, Funda
    Sood, Anil K.
    Conzen, Suzanne D.
    Hortobagyi, Gabriel N.
    Gonzalez-Angulo, Ana-Maria
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (19) : 2645 - 2652
  • [33] ENFORCED TUMOR SPECIFIC MHC-I HETEROGENEITY IN TRIPLE NEGATIVE BREAST CANCER DRIVES IMMUNOTHERAPY RESISTANCE
    Taylor, Brandie
    Balko, Justin
    Sanders, Melinda
    Gonzalez-Ericsson, Paula
    Sanchez, Violeta
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A342 - A342
  • [34] Common Breast Cancer Susceptibility Loci Are Associated with Triple-Negative Breast Cancer
    Stevens, Kristen N.
    Vachon, Celine M.
    Lee, Adam M.
    Slager, Susan
    Lesnick, Timothy
    Olswold, Curtis
    Fasching, Peter A.
    Miron, Penelope
    Eccles, Diana
    Carpenter, Jane E.
    Godwin, Andrew K.
    Ambrosone, Christine
    Winqvist, Robert
    Brauch, Hiltrud
    Schmidt, Marjanka K.
    Cox, Angela
    Cross, Simon S.
    Sawyer, Elinor
    Hartmann, Arndt
    Beckmann, Matthias W.
    Schulz-Wendtland, Ruediger
    Ekici, Arif B.
    Tapper, William J.
    Gerty, Susan M.
    Durcan, Lorraine
    Graham, Nikki
    Hein, Rebecca
    Nickels, Stephan
    Flesch-Janys, Dieter
    Heinz, Judith
    Sinn, Hans-Peter
    Konstantopoulou, Irene
    Fostira, Florentia
    Pectasides, Dimitrios
    Dimopoulos, Athanasios M.
    Fountzilas, George
    Clarke, Christine L.
    Balleine, Rosemary
    Olson, Janet E.
    Fredericksen, Zachary
    Diasio, Robert B.
    Pathak, Harsh
    Ross, Eric
    Weaver, JoEllen
    Ruediger, Thomas
    Forsti, Asta
    Duennebier, Thomas
    Ademuyiwa, Foluso
    Kulkarni, Swati
    Pylkaes, Katri
    CANCER RESEARCH, 2011, 71 (19) : 6240 - 6249
  • [35] Survival Study of Triple-Negative and Non-Triple-Negative Breast Cancer in a Brazilian Cohort
    Goncalves, Homero, Jr.
    Guerra, Maximiliano Ribeiro
    Duarte Cintra, Jane Rocha
    Fayer, Vivian Assis
    Brum, Igor Vilela
    Bustamante Teixeira, Maria Teresa
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2018, 12
  • [36] MHC Class I Loss in Triple-negative Breast Cancer A Potential Barrier to PD-1/PD-L1 Checkpoint Inhibitors
    Dusenbery, Anna C.
    Maniaci, Joseph L.
    Hillerson, Natalie D.
    Dill, Erik A.
    Bullock, Timothy N.
    Mills, Anne M.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2021, 45 (05) : 701 - 707
  • [37] Integrating leptin and cAMP pathways in triple-negative breast cancer cells
    Spina, Annamaria
    Di Maiolo, Francesca
    Esposito, Antonietta
    D'Auria, Raffaella
    Di Gesto, Davide
    Chiosi, Emilio
    Sorvillo, Luca
    Naviglio, Silvio
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2013, 18 : 133 - 144
  • [38] How I treat metastatic triple-negative breast cancer
    Caparica, Rafael
    Lambertini, Matteo
    de Azambuja, Evandro
    ESMO OPEN, 2019, 4
  • [39] Triple-Negative Breast Cancer: Not Entirely Negative
    Leone, Jose Pablo
    Puhalla, Shannon
    ONCOLOGY-NEW YORK, 2013, 27 (09): : 856 - +
  • [40] Adipogenesis in triple-negative breast cancer is associated with unfavorable tumor immune microenvironment and with worse survival
    Masanori Oshi
    Yoshihisa Tokumaru
    Fernando A. Angarita
    Lan Lee
    Li Yan
    Ryusei Matsuyama
    Itaru Endo
    Kazuaki Takabe
    Scientific Reports, 11